INFI

Infinity Pharmaceuticals, Inc.
INFI

Overview Fund Activity
Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

45 hedge funds and large institutions have $4.23M invested in Infinity Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-8
Holders Change %
-15.09%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
15
Closed
10
Calls
$25K
Puts
$4K
Net Calls
+$21K
Net Calls Change
+$7K

Top Buyers

1
Mariner
Mariner
Kansas
+$252K
2
CC
Carlson Capital
Texas
+$63.2K
3
Renaissance Technologies
Renaissance Technologies
New York
+$25.8K
4
EWM
Evercore Wealth Management
New York
+$15.2K
5
WIM
Wittenberg Investment Management
Massachusetts
+$12K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$62.9K
2
VF
Virtu Financial
New York
-$28.8K
3
Millennium Management
Millennium Management
New York
-$25.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$20.6K
5
UBS Group
UBS Group
Switzerland
-$11.1K
Name Holding Trade Value Shares
Change 		Shares
Change %
ASN
51
Advisory Services Network
Georgia
– -$128 -800 Closed
TWA
52
TCI Wealth Advisors
Arizona
– -$32 -200 Closed
QC
53
Quent Capital
New York
– -$15 -94 Closed
1 2
3